Introduction {#s1}
============

Establishment of neuronal morphology is a key process during neurodevelopment. The neuronal morphogenesis process involves the extension and the branching of axons and dendrites in order to allow each neuron to determine functional connections with other neurons. Indeed, perturbations of this process can cause severe deficits in brain functions in various neurodevelopmental disorders such as autism spectrum disorder, attention deficit hyperactive disorder, and schizophrenia ([@bib7]; [@bib19]; [@bib53]). Although its complex regulatory pathways composed of various players are still largely unknown, the orchestrated remodeling of the cytoskeleton is a crucial step for neuronal morphogenesis ([@bib16]; [@bib17]; [@bib48]).

Nuclear distribution element-like 1 (NDEL1) plays multifaceted roles in neurodevelopmental processes ([@bib14]). NDEL1 expression in the nervous system begins at early embryonic stage and is maintained throughout the adulthood ([@bib45]; [@bib50]). Deficiency in *Ndel1* results in embryonic lethality ([@bib51]) and postmortem studies and human genetic studies have implicated NDEL1 in several neuropsychiatric diseases such as schizophrenia ([@bib11]; [@bib13]; [@bib20]; [@bib33]; [@bib39]), both emphasizing the importance of NDEL1 functions in brain development. In the developing brain, NDEL1 regulates neuronal precursor proliferation and differentiation ([@bib32]; [@bib59]; [@bib70]), neuronal migration ([@bib42]; [@bib51]; [@bib57]; [@bib61]; [@bib71]), and neuronal maturation ([@bib22]; [@bib25]; [@bib27]; [@bib30]; [@bib49]; [@bib55]; [@bib71]). These functions are supposed to be regulated by multiple post-translational modifications (PTMs), but the detailed mechanism underlying them is yet fully understood.

NDEL1 directly binds to Trio-associated repeat on actin (TARA, also known as TRIOBP isoform 1) ([@bib23]), a short isoform of Trio-binding protein (TRIOBP) generated by alternative splicing ([@bib46]; [@bib54]). TARA associates with filamentous actin (F-actin) and has functions in cell mitosis and cell migration ([@bib23]; [@bib54]; [@bib72]). Although its abnormal aggregation has also been observed in the postmortem brains of patients with schizophrenia ([@bib9]; [@bib10]), the role of the TARA in neurodevelopment remains largely unknown. Furthermore, the molecular mechanisms underlying functions of NDEL1-TARA complex have yet to be unraveled.

Here, we introduced the large-scale human kinome library screening and the unbiased LC-MS/MS analysis of NDEL1 in order to systematically search regulatory mechanisms for its functions in brain development. We identified the novel sequential phosphorylation at S336 and S332 by DYRK2 and GSK3β and its function in neuronal morphogenesis, particularly in axon/dendrite outgrowth and neuronal arborization, through modulation of F-actin dynamics. We propose a new signaling mechanism that TARA scaffolds DYRK2 and GSK3β and recruits them to NDEL1, thereby inducing sequential phosphorylation of NDEL1 S336/S332 that is crucial for establishing the neuronal morphology. Taking together, our results provide a new biological insight to understand underlying mechanism for neuronal morphogenesis thereby for relevant neurodevelopmental disorders.

Results {#s2}
=======

DYRK2 and GSK3β induce sequential phosphorylation of NDEL1 at S336 and S332 {#s2-1}
---------------------------------------------------------------------------

In order to search regulatory mechanisms toward NDEL1 functions, we screened the human kinome library (Center for Cancer Systems Biology (Dana Farber Cancer Institute)-Broad Human Kinase ORF collection) for kinases responsible for NDEL1 phosphorylation ([@bib26]; [@bib69]). NDEL1 phosphorylation was determined by the band shift assay that has been shown to be effective in detecting phosphorylation of NDEL1 ([@bib40]; [@bib68]). Among the 218 serine/threonine kinases tested, we identified dual specificity tyrosine-phosphorylation-regulated kinase 2 (DYRK2) and homeodomain-interacting protein kinase 4 (HIPK4) as the candidates ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). DYRK2 and HIPK4 belong to the DYRK family and share an evolutionarily conserved DYRK homology (DH)-box ([@bib1]; [@bib2]; [@bib5]). Moreover, DYRK family kinases often act as priming kinases for GSK3 on various targets ([@bib15]; [@bib41]; [@bib60]; [@bib66]). Indeed, DYRK2 induced significant phosphorylation of NDEL1 while co-expression of DYRK2 and GSK3β^S9A^, a constitutively active form of GSK3β, induced at least two phosphorylation bands ([Figure 1A](#fig1){ref-type="fig"}). In silico analysis predicted NDEL1 S336 and S332 residues as the target sites by DYRK2 and GSK3β, respectively. When we tested each phospho-deficient mutant, S332A (NDEL1^S332A^) and S336A (NDEL1^S336A^), NDEL1^S332A^ retained a single phosphorylation band by DYRK2, but lost GSK3β effect, while either NDEL1^S336A^ or S332A/S336A double mutant (NDEL1^S332/336A^) showed no detectible phosphorylation band ([Figure 1B](#fig1){ref-type="fig"}, [Figure 1---figure supplement 2A](#fig1s2){ref-type="fig"}). It verified a sequential phosphorylation process, first at S336 by DYRK2 followed by at S332 by GSK3β.

![DYRK2 and GSK3β induce sequential phosphorylation of NDEL1 at S336 and S332.\
(**A**) Identification of responsible kinases for NDEL1 phosphorylation. DYRK2, one of the positive candidates from human kinome screening for NDEL1 phosphorylation, and GSK3β^S9A^ sequentially phosphorylated NDEL1. (**B**) Identification of NDEL1 S336 and S332 as target sites of DYRK2 and GSK3β. DYRK2 increased NDEL1 phosphorylation at S336 and GSK3β^S9A^ additionally induced phosphorylation at S332. (**C**) List of NDEL1 PTMs identified from LC-MS/MS analysis of developing mouse brain lysates. Peptide containing S336 and S332 phosphorylation is indicated by bold and underlined letters. (**D**) MS/MS spectrum for the phosphorylated fragments of NDEL1 peptide including S332 and S336 residues. The sequence of the peptide (aa 315--345) and all detected fragment ions are shown above. The b- and y-ions annotated in the spectrum include the sizes of y~14~ and b~22~ ions indicative of phosphorylation at S332 or S336. (**E**) Phosphorylation levels of endogenous NDEL1 S336/S332 in the developing mouse brain. Amount of lysates subjected to IP was normalized by NDEL1 protein levels. N = 7 for E15, P7, P14, P28, and adult brain lysates and N = 6 for E18. All results are presented as means ± SEM. (**F**) Increased endogenous NDEL1 phosphorylation by DYRK2 and GSK3β. Transfected HEK293 cell lysates were IPed with pan-NDEL1 antibody followed by western blot with anti-pNDEL1 antibody. Over-expression of DYRK2 and GSK3β^S9A^ increased the endogenous NDEL1 S336/S332 phosphorylation. The number of samples is shown at the bottom of the bar of the graph. All results are presented as means ± SEM. \*p\<0.05 from Student's t-test. (**G**) Endogenous NDEL1 S336/S332 phosphorylation detected at the growth cone of the primary cultured mouse hippocampal neuron. Anti-pNDEL1 antibody signal was enriched at the growth cone and colocalized with both phalloidin and α-tubulin (indicated by arrowheads). Magnified confocal images show the strong overlap between pNDEL1, phalloidin, and α-tubulin. The scale bar represents 10 μm. See also [Figure 1---figure supplements 1](#fig1s1){ref-type="fig"}, [2](#fig1s2){ref-type="fig"} and [3](#fig1s3){ref-type="fig"} and [Figure 1---source data 1](#fig1sdata1){ref-type="supplementary-material"} and [2](#fig1sdata2){ref-type="supplementary-material"}.\
Figure 1---source data 1.Source data for quantitation of endogenous pNDEL1 in developing mouse brain lysates.\
Figure 1---source data 2.Source data for quantitation of endogenous pNDEL1 with kinases over-expression.](elife-50850-fig1){#fig1}

We then assessed the PTMs of endogenous NDEL1 proteins isolated from postnatal day 7 (P7) developing mouse brain by LC-MS/MS analysis to see whether the S332 and 336 can be phosphorylated *in vivo* ([Figure 1C](#fig1){ref-type="fig"}, [Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}). Interestingly, among multiple PTMs identified, we observed masses indicating phosphorylation at NDEL1 S332 or S336 ([Figure 1D](#fig1){ref-type="fig"}), suggesting the potential roles of NDEL1 phosphorylation in neurodevelopmental processes.

To monitor the phosphorylation state of NDEL1 S336 and S332, we raised an NDEL1 S336/S332 phosphorylation-specific antibody (anti-pNDEL1). As detected by anti-pNDEL1 antibody, the phosphorylation was decreased in NDEL1^S332A^ and virtually absent in NDEL1^S336A^ ([Figure 1---figure supplement 2B](#fig1s2){ref-type="fig"}). Anti-pNDEL1 antibody also detected bands corresponding to endogenous NDEL1 proteins immunoprecipitated (IPed) from lysates of developing mouse brain ([Figure 1---figure supplement 2C](#fig1s2){ref-type="fig"}). In the brain lysates from various developmental stages, pNDEL1 signal peaked at embryonic day 18 (E18) and P7 ([Figure 1E](#fig1){ref-type="fig"}), the stage where residual neuronal migration and intense neurite outgrowth and maturation occur. Additionally, the increment of the endogenous NDEL1 phosphorylation by DYRK2-GSK3β^S9A^ expression was detected by anti-pNDEL1 antibody ([Figure 1F](#fig1){ref-type="fig"}).

The pNDEL1 signal in mouse brain slices was significantly diminished upon NDEL1 knockdown by *in utero* electroporation of an shRNA construct, further validating the immunostaining specificity of the antibody ([Figure 1---figure supplement 2D](#fig1s2){ref-type="fig"}). In cultured primary hippocampal neurons, the significant pNDEL1 signal was detected in the growth cone, a region of dynamic crosstalk between actin and microtubules ([Figure 1G](#fig1){ref-type="fig"}). This crosstalk is required for correct neurite extension and branching ([@bib16]; [@bib43]; [@bib48]). Moreover, the pNDEL1 signal overlapped with that of both phalloidin, a marker for F-actin, and α-tubulin. Notably, phosphorylated NDEL1 was prominently present in filopodia-like structures where both F-actin and microtubules are colocalized ([Figure 1G](#fig1){ref-type="fig"}, arrowheads).

Phosphorylation of NDEL1 S336/S332 regulates neuronal morphogenesis {#s2-2}
-------------------------------------------------------------------

The phosphorylated NDEL1 was colocalized with both actin and microtubules at the growth cone, thus we next examined the roles for NDEL1 S336/S332 phosphorylation in the neuronal development. In cultured hippocampal neurons, NDEL1 knockdown significantly reduced both the total neurite length and the longest neurite length by about 31% and 33%, respectively ([Figure 2A--C](#fig2){ref-type="fig"}). Co-expression of an shRNA-resistant form of NDEL1^WT^, but not NDEL1^S332/336A^, effectively reversed these phenotypes providing specificity to the NDEL1 phosphorylation. These NDEL1 phosphorylation-specific effects were found for both axonal and dendritic neurites ([Figure 2---figure supplement 1A--B](#fig2s1){ref-type="fig"}). In addition, co-expression of DYRK2 and GSK3β^S9A^ with NDEL1^WT^, but not with NDEL1^S332/336A^, significantly increased the total neurite length and the longest neurite length by about 22% and 19%, respectively ([Figure 2D--F](#fig2){ref-type="fig"}, [Figure 2---figure supplement 1C--D](#fig2s1){ref-type="fig"}). Furthermore, to avoid potential complications caused by an overexpression of NDEL1, we applied CRISPR/Cas9 based knock-in (KI) approach targeting mouse *Ndel1* exon nine in order to generate a phospho-deficient NDEL1 S332/336A mutation with insertion of EGFP as the KI marker ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}). NDEL1 S332/336A KI resulted in the diminished neurite lengths of the primary cultured neurons ([Figure 2G--I](#fig2){ref-type="fig"}, [Figure 2---figure supplement 1E--F](#fig2s1){ref-type="fig"}). Taken together, these results show that NDEL1 phosphorylation at S336 and S332 up-regulates axon/dendrite outgrowth.

![Phosphorylation of NDEL1 S336/S332 increases neurite outgrowth of primary cultured hippocampal neurons.\
(**A--C**) Suppression of NDEL1 S336/S332 phosphorylation inhibited neurite outgrowth of hippocampal neurons. Each DNA construct was transfected at 9 hr after neuronal culture and neurites of transfected neurons were analyzed at DIV 3. All of NDEL1 over-expressing constructs here contain an shRNA-resistant mutation. (**A**) Representative images of transfected neurons. The total neurite length (**B**) and the longest neurite length (**C**) were measured by using ImageJ software. (**D--F**) NDEL1 S336/S332 phosphorylation induced by DYRK2-GSK3β co-expression is enough to increase neurite outgrowth of hippocampal neurons. Each DNA construct was transfected at DIV 2 and neurites of transfected neurons were analyzed at DIV 5. (**D**) Representative images of transfected neurons. The total neurite length (**E**) and the longest neurite length (**F**) were measured by using ImageJ software. (**G--I**) KI of phospho-deficient mutations resulted in neurite outgrowth defects. DNA constructs for KI were transfected at DIV 1 and neurites of transfected neurons were analyzed at DIV 4. (**G**) Representative images of transfected neurons. The total neurite length (**H**) and the longest neurite length (**I**) were measured by using ImageJ software. Each sample number is shown at the bottom of the bar of the graph. Scale bars represent 100 μm. All results are presented as means ± SEM. \*p\<0.05, \*\*p\<0.01, and \*\*\*p\<0.001 from one-way ANOVA for (**B**), (**C**), (**E**), and (**F**) and Student's t-test for (**H**) and (**I**). All experiments were independently repeated at least three times. See also [Figure 2---figure supplements 1](#fig2s1){ref-type="fig"} and [2](#fig2s2){ref-type="fig"} and [Figure 2---source data 1](#fig2sdata1){ref-type="supplementary-material"}, [2](#fig2sdata2){ref-type="supplementary-material"} and [3](#fig2sdata3){ref-type="supplementary-material"}.\
Figure 2---source data 1.Source data for axon/dendrite outgrowth of NDEL1 knockdown and rescue groups.\
Figure 2---source data 2.Source data for axon/dendrite outgrowth of NDEL1 and kinases over-expression groups.\
Figure 2---source data 3.Source data for axon/dendrite outgrowth assay of NDEL1 S332/336A KI.](elife-50850-fig2){#fig2}

Suppression of NDEL1 expression in mouse brain decreases the number of dendritic branches ([@bib49]). In *Drosophila*, the loss of NudE, a homolog of both NDE1 and NDEL1, results in abnormal dendritic arborization ([@bib3]). Thus, we next examined the roles of NDEL1 phosphorylation in the arborization of dendrites in the developing mouse brain. NDEL1 S336/S332 phosphorylation was prominently detected in neurons of the cortical layers II/III in P14 mouse brain ([Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"}). Thus, we analyzed the dendritic structure of the pyramidal neurons in layers II/III at P14. NDEL1 knockdown decreased the number of intersections in Sholl analysis and the total length of dendrites ([Figure 3A--C](#fig3){ref-type="fig"}, [Figure 3---video 1](#fig3video1){ref-type="video"}), in addition to the abnormal positioning of cortical neurons as previously reported ([Figure 3A](#fig3){ref-type="fig"}, arrowheads). Co-expression of an shRNA-resistant form of NDEL1^WT^, but not NDEL1^S332/336A^, reversed this defect in dendritic arborization. The total number of dendritic branches decreased upon suppression of NDEL1 phosphorylation with no significant change in the longest dendritic branch length ([Figure 3D](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1B](#fig3s1){ref-type="fig"}). The effect was similar at both apical and basal dendrites ([Figure 3---figure supplement 1C--F](#fig3s1){ref-type="fig"}). In addition, suppression of NDEL1 phosphorylation resulted in decreased numbers of secondary and tertiary dendrites ([Figure 3E](#fig3){ref-type="fig"}). Conversely, over-expression of NDEL1^WT^ and responsible kinases increased the total length and the branching number of dendrites with more intersections in Sholl analysis ([Figure 3F--J](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1G--K](#fig3s1){ref-type="fig"}, and [Figure 3---video 2](#fig3video2){ref-type="video"}). We also utilized human ubiquitin C (UBC) promoter to drive the expression of transgene at lower level and observed comparable effect of the phospho-deficient mutants ([Figure 2---figure supplement 1G--K](#fig2s1){ref-type="fig"} and [Figure 3---figure supplement 1L--N](#fig3s1){ref-type="fig"}). NDE1, a paralog of NDEL1 lacking C-terminal region harboring S336 and S332 residues, failed to effectively rescue neurite defects caused by NDEL1 KD ([Figure 2---figure supplement 1L--O](#fig2s1){ref-type="fig"}). Although *in utero* electroporation is intrinsically cell-type nonspecific and thus we cannot fully exclude the contribution of neuron-nonautonomous effects from neural or glial progenitors, these results collectively indicate that NDEL1 phosphorylation at S336 and S332 plays critical roles for neuronal arborization.

![Phosphorylation of NDEL1 S336/S332 regulates dendritic arborization of cortical pyramidal neurons.\
(**A--E**) Suppression of NDEL1 S336/S332 phosphorylation disrupted dendritic arborization of layer II/III pyramidal neurons. All constructs were electroporated *in utero* to E15 mouse brain and then P14 brain was subjected for analysis. All of NDEL1 over-expressing constructs here contain an shRNA-resistant mutation. (**A**) Representative images of the brain slices with the tracked neuron (above) and the overlapped dendritic structures of five independent neurons (bottom). Sholl analysis plots (**B**), the total length of dendrites (**C**), the total number of branches (**D**), and the number of primary/secondary/tertiary dendrites (**E**) were analyzed by using Simple neurite tracer plug-in of ImageJ software. White arrowheads in (**A**) indicate neurons with migration defect. (**F--J**) NDEL1 S336/S332 phosphorylation induced by DYRK2-GSK3β kinases increased dendritic arborization of layer II/III pyramidal neurons. All constructs were electroporated *in utero* to E15 mouse brain and P14 brain was subjected for analysis. (**F**) Representative images of the brain slices with the tracked neuron (above) and the overlapped dendritic structures of five independent neurons (bottom). Sholl analysis plots (**G**), the total length of dendrites (**H**), the total number of branches (**I**), and the number of primary/secondary/tertiary dendrites (**J**) were analyzed by using Simple neurite tracer plug-in of ImageJ software. Each n number is shown at the bottom of the bar of the graph. Scale bars represent 100 μm. All results are presented as means ± SEM. \*p\<0.05, \*\*p\<0.01, and \*\*\*p\<0.001 from one-way ANOVA for (**C**), (**D**), (**H**), and (**I**) and two-way ANOVA for (**B**), (**E**), (**G**), and (**J**). All brain samples for each group were collected from offspring of at least three independent *in utero* electroporation surgeries. See also [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}, [Figure 3---videos 1](#fig3video1){ref-type="video"} and [2](#fig3video2){ref-type="video"}, and [Figure 3---source data 1](#fig3sdata1){ref-type="supplementary-material"} and [2](#fig3sdata2){ref-type="supplementary-material"}.\
Figure 3---source data 1.Source data for dendritic arborization of NDEL1 knockdown and rescue groups.\
Figure 3---source data 2.Source data for dendritic arborization of NDEL1 and kinases over-expression groups.](elife-50850-fig3){#fig3}

TARA recruits DYRK2 and GSK3β to induce sequential phosphorylation of NDEL1 S336/S332 {#s2-3}
-------------------------------------------------------------------------------------

The interaction between NDEL1 and TARA has been identified previously ([@bib23]). Interestingly, TARA co-expression introduced at least two additional forms of NDEL1 bands distinct in size ([Figure 4A](#fig4){ref-type="fig"}). Moreover, deletion of the NDEL1-interacting domain, hTARA^Δ413-499^ ([@bib23]) or mTARA^Δ401-487^, effectively blocked the band shift ([Figure 4---figure supplement 1A--B](#fig4s1){ref-type="fig"}). To test whether the band mobility shifts are caused by PTMs, we treated protein phosphatase *in vitro* and it significantly diminished the mobility shifts of NDEL1 bands ([Figure 4A](#fig4){ref-type="fig"}). In addition, TARA enhanced the signals detected by phosphoserine-specific antibody (anti-PhosphoSerine) ([Figure 4---figure supplement 1C](#fig4s1){ref-type="fig"}). These results indicate that the NDEL1-TARA interaction promotes NDEL1 phosphorylation.

![TARA recruits DYRK2 and GSK3β to induce sequential phosphorylation of NDEL1 S336/S332.\
(**A**) *In vitro* phosphatase assay. Calf intestinal alkaline phosphatase (CIP) was treated *in vitro* after IP of FLAG-tagged NDEL1. Additional bands of NDEL1 disappeared upon CIP treatment indicating that these additional bands are caused by the multiple phosphorylation. (**B**) MS/MS spectrum for the phosphorylated fragments of NDEL1 peptide including S332 and S336 residues. NDEL1 proteins from HEK293 cells over-expressing NDEL1 and TARA were subjected to LC-MS/MS analysis. The sequence of the peptide (aa 306--345) and all detected fragment ions are shown above. The b- and y-ions annotated in the spectrum include the sizes of y~12~ and b~33~ ions indicative of a single phosphorylation at either S335 or S336. (**C**) TARA-induced NDEL1 phosphorylation S336 and S332. TARA increased sequential phosphorylation of NDEL1, first at S336 followed by S332. (**D**) The protein-protein interaction between DYRK2 and TARA. Endogenous DYRK2 was co-precipitated by IP of endogenous TARA from HEK293 cell lysates. Rabbit IgG was used as a negative control. At input lanes, 1% and 10% of lysates were loaded for anti-DYRK2 and anti-TARA blots, respectively. (**E**) The protein-protein interaction between GSK3β and TARA. Endogenous TARA was co-precipitated by IP of endogenous GSK3β proteins from HEK293 cell lysates. Mouse IgG was used as a negative control. (**F**) Co-IP among DYRK2, GSK3β, and TARA. Over-expression of TARA increased an amount of GSK3β proteins co-precipitated by IP of DYRK2, implying that TARA scaffolds these kinases to form a DYRK2-GSK3β-TARA tripartite complex. (**G**) Colocalization of DYRK2, GSK3β, and TARA in mouse hippocampal neurons. GFP-hDYRK2, FLAG-hGSK3β, and MYC-hTARA colocalized at the soma (above) and the growth cone (bottom) regions. See also [Figure 4---figure supplements 1](#fig4s1){ref-type="fig"} and [2](#fig4s2){ref-type="fig"}. The following figure supplement is available for [Figure 4](#fig4){ref-type="fig"}.](elife-50850-fig4){#fig4}

To characterize the TARA-dependent NDEL1 phosphorylation, we utilized LC-MS/MS analysis of FLAG-NDEL1 proteins upon co-expression of NDEL1 and TARA in HEK293 cells ([Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}). Among the multiple PTMs detected, a phospho-peptide containing S336 residue was present ([Figure 4B](#fig4){ref-type="fig"}). The phosphorylations of both S336 and S332 in a single peptide were not recovered, in part due to technical limitations of LC-MS/MS. When we tested each single alanine mutant, NDEL1^S332A^ and NDEL1^S336A^ showed decreased TARA-dependent phosphorylation ([Figure 4C](#fig4){ref-type="fig"}, [Figure 4---figure supplement 1D](#fig4s1){ref-type="fig"}). Particularly, NDEL1^S332A^ showed only a single phosphorylation band, while NDEL1^S336A^ showed a significant reduction in both phosphorylation bands.

To assess how TARA increases NDEL1 phosphorylation by DYRK2-GSK3β kinases, we tested protein-protein interactions among TARA and the kinases. Endogenous TARA was co-IPed with both DYRK2 and GSK3β ([Figure 4D--E](#fig4){ref-type="fig"}). Furthermore, over-expression of TARA enhanced the interaction between DYRK2 and GSK3β, suggesting that TARA acts as a scaffold ([Figure 4F](#fig4){ref-type="fig"}). Immunocytochemistry analysis confirmed their colocalization, further supporting their functional association ([Figure 4G](#fig4){ref-type="fig"}).

In cultured neurons, the co-expression of NDEL1^WT^, but not NDEL1^S332/336A^, with TARA significantly increased both the total neurite length and the longest neurite length ([Figure 5A--C](#fig5){ref-type="fig"}, [Figure 5---figure supplement 1A--B](#fig5s1){ref-type="fig"}). On the other hand, co-expression of NDEL1^WT^ and hTARA^Δ413-499^, which did not induce notable NDEL1 phosphorylation, did not increase the total neurite length and the longest neurite length ([Figure 5D--F](#fig5){ref-type="fig"}, [Figure 5---figure supplement 1C--D](#fig5s1){ref-type="fig"}). Consistently, in P14 brain slices, only neurons expressing NDEL1^WT^ with TARA had a greater total dendrite length and more branches dependently to the phosphorylation ([Figure 5G--K](#fig5){ref-type="fig"}, [Figure 5---figure supplement 1E--I](#fig5s1){ref-type="fig"}, and [Figure 5---video 1](#fig5video1){ref-type="video"}).

![NDEL1 S336/S332 phosphorylation induced by TARA increases neurite outgrowth and dendritic arborization.\
(**A--C**) Induction of NDEL1 S336/S332 phosphorylation by TARA increased neurite outgrowth. Each DNA construct was transfected at DIV 2 and neurites of transfected neurons were analyzed at DIV 5. (**A**) Representative images of transfected neurons. The total neurite length (**B**) and the longest neurite length (**C**) were measured by using ImageJ software. (**D--F**) TARA^Δ413-499^ could not increase neurite outgrowth. Each DNA construct was transfected at DIV 2 and neurites of transfected neurons were analyzed at DIV 5. (**D**) Representative images of transfected neurons. The total neurite length (**E**) and the longest neurite length (**F**) were measured by using ImageJ software. (**G--K**) Up-regulated NDEL1 S336/S332 phosphorylation increased dendritic arborization of layer II/III pyramidal neurons. All constructs were electroporated *in utero* to E15 mouse brain and P14 brain was subjected for analysis. (**G**) Representative images of the brain slices with the tracked neuron (above) and the overlapped dendritic structures of five independent neurons (bottom). Sholl analysis plots (**H**), the total length of dendrites (**I**), the total number of branches (**J**), and the number of primary/secondary/tertiary dendrites (**K**) were analyzed by using Simple neurite tracer plug-in of ImageJ software. Each n number is shown at the bottom of the bar of the graph. Scale bars represent 100 μm. All results are presented as means ± SEM. \*\*p\<0.01 and \*\*\*p\<0.001 from one-way ANOVA for (**B**), (**C**), (**E**), (**F**), (**I**), and (**J**) and two-way ANOVA for (**H**) and (**K**). All neurite outgrowth experiments for (**A--C**) and (**D--F**) were independently repeated for at least three times. All brain samples for each group of (**G--K**) were collected from offspring of at least three independent *in utero* electroporation surgeries. See also [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}, [Figure 5---video 1](#fig5video1){ref-type="video"}, and [Figure 5---source data 1](#fig5sdata1){ref-type="supplementary-material"} and [2](#fig5sdata2){ref-type="supplementary-material"}.\
Figure 5---source data 1.Source data for axon/dendrite outgrowth of NDEL1 and TARA over-expression groups.\
Figure 5---source data 2.Source data for dendritic arborization of NDEL1 and TARA over-expression groups.](elife-50850-fig5){#fig5}

Thus, these results indicate that TARA recruits DYRK2 and GSK3β to induce NDEL1 S336/S332 phosphorylation, thereby enhancing neuronal morphogenesis.

Phosphorylation of NDEL1 S336/S332 enhances F-actin dynamics {#s2-4}
------------------------------------------------------------

We then looked for the underlying mechanism by which NDEL1 S336/S332 phosphorylation increases axon/dendrite outgrowth and neuronal arborization. Since we observed anti-pNDEL1 antibody signal overlapping with both F-actin and microtubule at the growth cone ([Figure 1G](#fig1){ref-type="fig"}), we tested if NDEL1 S336/S332 phosphorylation affects cytoskeletal dynamics.

TARA directly binds to and stabilizes the F-actin structure and it recruits NDEL1 toward F-actin ([@bib23]; [@bib54]). When we isolated F-actin from soluble G-actin via F-actin fractionation protocol, NDEL1 S336/S332 phosphorylation induced by TARA was detected in both insoluble F-actin fraction and soluble G-actin fraction, verifying that it can associate with F-actin structure ([Figure 6A](#fig6){ref-type="fig"}) comparable to its colocalization at growth cone ([Figure 1G](#fig1){ref-type="fig"}). Furthermore, we employed fluorescence recovery after photobleaching (FRAP) in combination with transfection of RFP-LifeAct to measure F-actin dynamics in the growth cone-like structure of differentiating SH-SY5Y cells ([@bib6]; [@bib47]). NDEL1 knockdown suppressed the fluorescence recovery without changing the half-maximum recovery time ([Figure 6B--F](#fig6){ref-type="fig"}, [Figure 6---figure supplement 1A--D](#fig6s1){ref-type="fig"}, and [Figure 6---video 1](#fig6video1){ref-type="video"}). Co-expression of an shRNA-resistant form of NDEL1^WT^, but not NDEL1^S332/336A^, significantly rescued the impaired F-actin dynamics indicating its phosphorylation dependency. Reduced amount of fluorescence recovery can be interpreted as either by the more stable F-actin structures or by the less newly formed F-actin. Since NDEL1 S336/S332 phosphorylation had a minimal effect on an insoluble fraction of F-actin fraction, it is more likely that suppression of NDEL1 phosphorylation reduced F-actin formation.

![Phosphorylation of NDEL1 S336/S332 modulates F-actin dynamics.\
(**A**) F-actin fractionation assay of NDEL1 and TARA. NDEL1 S336/S332 phosphorylation induced by TARA was observed at both G-actin in the supernatant fraction (S) and F-actin in pellet fraction (P). (**B--F**) Decreased F-actin dynamics by suppression of NDEL1 S336/S332 phosphorylation. (**B**) Representative time-lapse images of FRAP assay to measure F-actin dynamics at differentiating SH-SY5Y cells expressing RFP-LifeAct. All of NDEL1 over-expressing constructs here contain an shRNA-resistant mutation. A yellow-dashed circle indicates region-of-interest used for bleaching. Bleaching was given by stimulating with 10% 568 nm laser for 10 s. (**C**) Time-dependent fluorescence recovery graph. Comparisons of the area under FRAP curves (**D**), the percentage of mobile F-actin fraction calculated by the amount of eventual fluorescence recovery (**E**), and the average half-max (t~1/2~) of RFP-LifeAct fluorescence recovery (**F**). NDEL1 knockdown cells had decreased fluorescence recovery meaning more immobile fraction of F-actin and could not be rescued by NDEL1^S332/336A^ implying its phosphorylation dependency. Each n number is shown at the bottom of the bar of the graph. The scale bar at (**B**) represents 10 μm. All results are presented as means ± SEM. \*p\<0.05, \*\*p\<0.01, and \*\*\*p\<0.001 from two-way ANOVA for (**C**) and one-way ANOVA for (**D--F**). See also [Figure 6---figure supplements 1](#fig6s1){ref-type="fig"}, [2](#fig6s2){ref-type="fig"} and [3](#fig6s3){ref-type="fig"}, [Figure 6---video 1](#fig6video1){ref-type="video"}, and [Figure 6---source data 1](#fig6sdata1){ref-type="supplementary-material"}.\
Figure 6---source data 1.Source data for F-actin FRAP assay of NDEL1 knockdown and rescue groups.](elife-50850-fig6){#fig6}

On the other hand, we tested microtubule dynamics by FRAP assay with mCherry-α-tubulin ([Figure 6---figure supplement 1E--L](#fig6s1){ref-type="fig"}). Co-expression of either NDEL1^WT^ or NDEL1^S332/336A^ with NDEL1 shRNA enhanced microtubule dynamics and the effect was not distinguishable. While NDEL1 regulates microtubule dynamics in collaboration with dynein-LIS1 ([@bib14]; [@bib40]; [@bib67]), interactions between NDEL1 and either dynein intermediate chain (DYNC1I1) or LIS1 was not significantly affected by the phosphorylations ([Figure 6---figure supplement 2](#fig6s2){ref-type="fig"}). Furthermore, when we tested lysosomal trafficking in neurons as a readout for NDEL1-LIS1-dynein activity ([@bib28]; [@bib44]), both NDEL1^WT^ and NDEL1^S332/336A^ increased a retrograde movement of GFP-LAMP1 labeled lysosomes ([Figure 6---figure supplement 3](#fig6s3){ref-type="fig"}).

Taken together, our results indicate that NDEL1 phosphorylation at S336 and S332 up-regulates F-actin dynamics, at the growth cone of extending neurites, which is likely to underlie neuronal morphogenesis.

Discussion {#s3}
==========

In this study, we have identified a novel mechanism underlying neuronal morphogenesis that sequential phosphorylation of NDEL1 at S336 and S332 mediated by the TARA-DYRK2-GSK3β complex promotes the modulation of F-actin dynamics to impact this process ([Figure 7](#fig7){ref-type="fig"}).

![A model for the mechanism by which NDEL1 S336/S332 phosphorylation regulates neuronal morphogenesis.\
The phosphorylation of NDEL1 at S336 by DYRK2 primes S332 phosphorylation by GSK3β. TARA mediates this process by recruiting DYRK2 and GSK3β to NDEL1 and forming a tripartite complex in association with F-actin. The phosphorylated NDEL1 enhances F-actin dynamics at the interface with microtubule cytoskeleton in growth cones, thereby facilitating axon/dendrite length and neuronal arborization.](elife-50850-fig7){#fig7}

The identification of the TARA-DYRK2-GSK3β signaling module may allow the discovery of novel mechanisms and players in the neuronal morphogenesis. The concerted action of DYRK2 and GSK3 on substrates, such as eIF2Bε, tau, CRMP4, DCX, c-Jun, and c-Myc ([@bib15]; [@bib41]; [@bib58]; [@bib60]; [@bib62]; [@bib65]; [@bib66]), has implicated these kinases in cell cycle, neurite outgrowth, neuronal migration, microtubule regulation, and apoptosis. In these processes, DYRK2 primes the substrate followed by the preferential action of GSK3 at a nearby residue. Likewise, TARA also functions in cell mitosis, migration, and neurite outgrowth ([@bib10]; [@bib23]; [@bib72]), suggesting that it may co-operate with these kinases to modulate these cellular functions. Here, we newly identified TARA directly binds to DYRK2 and GSK3β and recruits them to NDEL1 for phosphorylation at S336 and S332, respectively. NDEL1 S336 is the priming site; once mutated, phosphorylation at S332 no longer occurs. Furthermore, enhancing TARA expression augments NDEL1 phosphorylation by DYRK2 and GSK3β. Taken together, our results indicate that TARA acts as a molecular scaffold to functionally link these two kinases to NDEL1. Of particular note, TARA and CRMP1, another substrate of GSK3, have been identified in insoluble aggregates present in brain samples of schizophrenia patients ([@bib4]), hinting at the potential involvement of TARA-DYRK2-GSK3β signaling module in the associated disease pathogenesis.

NDEL1 S336/S332 phosphorylation may highlight the functional difference between NDEL1 and its paralog NDE1. The C-terminal of NDEL1 (aa 191--345) contains multiple phosphorylation sites that are targeted by Aurora A and CDK1/CDK5 ([@bib36]; [@bib40]). Here, we identified and characterized two novel sites, S336 and S332, that are also located in the C-terminus. Interestingly, these TARA-DYRK2-GSK3β responsible sites, but not other phosphorylation sites, are absent in NDE1, a paralog of NDEL1 ([@bib8]; [@bib36]; [@bib40]; [@bib56]). Indeed, the function of NDEL1 S336/S332 phosphorylation in axon/dendrite outgrowth is not shared by NDE1 ([Figure 2---figure supplement 1L--O](#fig2s1){ref-type="fig"}). Thus, we expect that other NDEL1-specific functions are also regulated by S336/S332 phosphorylation. On the other hand, recently, Okamoto et al. determined that suppression of DISC1-binding zinc finger protein (DBZ) enhances the dual phosphorylation of NDEL1 at T219 and S251 by CDK5 and Aurora A, respectively ([@bib42]). This dual phosphorylation inhibits LIS1-DISC1 transport to the neurite tips and thus microtubule elongation, thereby inhibiting radial migration of neurons. Interestingly, phosphorylation by CDK5 alone enhances neuronal migration via increasing NDEL1 binding to katanin p60 ([@bib64]). Similarly, phosphorylation at S251 by Aurora A alone increases radial migration ([@bib61]). These results indicate that dual phosphorylation of NDEL1 can have distinct effects to those elicited by single phosphorylation, and similar regulation may also exist regarding NDEL1 S336/S332 phosphorylation and TARA-DYRK2-GSK3β signaling.

The actin-microtubule crosstalk is critical for neuronal morphogenesis ([@bib16]; [@bib18]; [@bib43]; [@bib48]). TARA directly associates to F-actin ([@bib54]) while NDEL1 regulates actin, microtubules, and intermediate filaments ([@bib23]; [@bib38]; [@bib40]; [@bib55]; [@bib63]). We previously showed that TARA recruits NDEL1 toward the cell periphery and together they up-regulate local F-actin levels ([@bib23]). Here, we showed that TARA-DYRK2-GSK3β axis promotes NDEL1 S336/S332 phosphorylation to modulate F-actin dynamics ([Figure 6](#fig6){ref-type="fig"}). We also observed this phosphorylation to be prominent in the neuronal growth cone where they colocalize with both F-actin and microtubules ([Figure 1G](#fig1){ref-type="fig"}). Some proteins involved in the actin-microtubule crosstalk, such as EB3, Drebrin, and CLIP-170, modulate F-actin dynamics while bound to microtubules ([@bib24]; [@bib31]; [@bib35]). Likewise, we postulate that NDEL1 may be associated with microtubule and simultaneously up-regulate F-actin dynamics, enhancing actin-microtubule crosstalk at growth cones. Also, we cannot exclude the possibility that TARA-mediated phosphorylation modulates the association of NDEL1 with microtubule. Additional investigations in this regard are required for further understanding how NDEL1 modulate the actin-microtubule crosstalk.

In summary, we have identified the sequential phosphorylation of NDEL1 at S336 and S332 mediated by the TARA-DYRK2-GSK3β complex as a novel regulatory mechanism for neuronal morphogenesis through modulating F-actin dynamics. Harnessing the biology of NDEL1 S336/S332 phosphorylation or the TARA-DYRK2-GSK3β signaling module will provide new insights toward the discovery of novel components and pathways that are pertinent to brain development and neurodevelopmental disorders.

Materials and methods {#s4}
=====================

Animals {#s4-1}
-------

Pregnant Sprague Dawley (SD) rat and ICR mice were purchased from Hyochang Science (Daegu, South Korea) and used for primary hippocampal neuron culture, brain lysate preparation, and *in utero* electroporation surgery. All animal procedures were approved by the Institutional Animal Care and Use Committee (IACUC) of Pohang University of Science and Technology (POSTECH-2019--0024 and POSTECH-2019--0025). All experiments were carried out in accordance with the approved guidelines.

Antibodies and plasmids {#s4-2}
-----------------------

Anti-NDEL1 rabbit polyclonal antibody (Cat\# 17262--1-AP, RRID:[AB_2235821](https://scicrunch.org/resolver/AB_2235821)) was purchased from Proteintech Group (Rosemont, IL, USA). Anti-TARA rabbit polyclonal antibody (Cat\# PA5-29092, RRID:[AB_2546568](https://scicrunch.org/resolver/AB_2546568)) was purchased from Thermo Fisher Scientific (Waltham, MA, USA). The NDEL1 S336/S332 phosphorylation-specific antibody (anti-pNDEL1) was generated and purified from rabbit blood serum after repetitive immunizations with KLH-conjugated phospho-NDEL1 peptide (KLH-C-GLGSpSRPSpSAPG, AbClon). Anti-GSK-3beta mouse monoclonal (Cat\# 9832, RRID:[AB_10839406](https://scicrunch.org/resolver/AB_10839406), Cell Signaling Technology, Danvers, MA, USA) and anti-DYRK2 mouse monoclonal (Cat\# MA5-24269, RRID:[AB_2606267](https://scicrunch.org/resolver/AB_2606267), Thermo Fisher Scientific) were used for IP and immunoblotting experiments. Anti-FLAG rabbit polyclonal and mouse monoclonal (Cat\# F7425, RRID:[AB_439687](https://scicrunch.org/resolver/AB_439687) and Cat\# F1804, RRID:[AB_262044](https://scicrunch.org/resolver/AB_262044), respectively, Sigma-Aldrich, St. Louis, MO, USA), anti-GFP rabbit polyclonal (Cat\# A-11122, RRID:[AB_221569](https://scicrunch.org/resolver/AB_221569), Molecular Probes, Eugene, OR, USA), anti-GFP mouse monoclonal (Cat\# sc-9996, RRID:[AB_627695](https://scicrunch.org/resolver/AB_627695), Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti-α-tubulin mouse monoclonal (Cat\# sc-32293, RRID:[AB_628412](https://scicrunch.org/resolver/AB_628412), Santa Cruz Biotechnology, and Cat\# 66031--1-Ig, RRID:[AB_11042766](https://scicrunch.org/resolver/AB_11042766), Proteintech Group), and anti-c-Myc mouse monoclonal (Cat\# sc-40, RRID:[AB_627268](https://scicrunch.org/resolver/AB_627268), Santa Cruz Biotechnology) were used for immunoblotting, IP, and immunostaining experiments. Anti-actin goat polyclonal (Cat\# sc-1616, RRID:[AB_630836](https://scicrunch.org/resolver/AB_630836), Santa Cruz Biotechnology) and PhosphoSerine Antibody Q5 (37430, Qiagen, Germantown, MD, USA) were used for immunoblotting. As a negative control for immunostaining and IP, normal rabbit IgG (Cat\# sc-2027, RRID:[AB_737197](https://scicrunch.org/resolver/AB_737197), Santa Cruz Biotechnology, and Cat\# ab37415, RRID:[AB_2631996](https://scicrunch.org/resolver/AB_2631996), Abcam, Cambridge, UK) and normal mouse IgG (Cat\# sc-2025, RRID:[AB_737182](https://scicrunch.org/resolver/AB_737182), Santa Cruz Biotechnology) were used. For immunoblotting, HRP-conjugated sheep anti-mouse IgG (Cat\# NA931, RRID:[AB_772210](https://scicrunch.org/resolver/AB_772210), GE Healthcare, Buckinghamshire, UK) and donkey anti-rabbit IgG (Cat\# NA934, RRID:[AB_772206](https://scicrunch.org/resolver/AB_772206), GE Healthcare) were used as secondary antibodies. For immunoblotting of IP, VeriBlot for IP Detection Reagent (HRP) (Cat\# ab131366, Abcam) was also used as secondary antibody. For immunostaining, Alexa Fluor 488, Alexa Fluor 568, or Flamma 648 conjugated goat anti-rabbit IgG (Cat\# A-11008, RRID:[AB_143165](https://scicrunch.org/resolver/AB_143165) and Cat\# A-11011, RRID:[AB_143157](https://scicrunch.org/resolver/AB_143157), Molecular Probes and Cat\# RSA1261, BioActs, Incheon, South Korea) and Alexa Fluor 488 or 568 conjugated goat anti-mouse antibodies (Cat\# A-11004, RRID:[AB_141371](https://scicrunch.org/resolver/AB_141371) and Cat\# A-21235, RRID:[AB_141693](https://scicrunch.org/resolver/AB_141693), Molecular Probes) were used as secondary antibodies.

All constructs for human *NDEL1*, human *TRIOBP* (isoform 1, hTARA), and mouse *Triobp* (isoform 1, mTARA) were prepared by cloning into pFLAG-CMV2 (Sigma-Aldrich), pEGFP-C3 (Clontech, Mountain View, CA, USA), and pcDNA3.1/myc-His (Invitrogen). Constructs for human *DYRK2* (hDYRK2) and human *GSK3B* (hGSK3β) were cloned into pEGFP-C3 and pFLAG-CMV2. The construct for mouse *Nde1* (NCBI nucleotide ID: NM_023317.2) was prepared by cloning into pCIG2-mRFP vector. All shRNA constructs were designed by cloning 19--21 nt of core sequences combined with TTCAAGAGA as the loop sequence into pLentiLox3.7 vector as described previously ([@bib12]; [@bib23]). Core sequences of NDEL1 shRNA, responsible to both human *NDEL1* and mouse and rat *Ndel1*, and hTARA shRNA were GCAGGTCTCAGTGTTAGAA and GCTGACAGATTCAAGTCTCAA, respectively, as we described previously ([@bib23]; [@bib38]). The core sequence of control scrambled shRNA was CTACCGTTGTATAGGTG. All constructs for *in utero* electroporation were cloned into pCIG2-mRFP, pCIG2-EGFP, and pUBC vectors. All expression constructs for human kinome library were cloned into pEZYmyc-His (Addgene plasmid \# 18701) and pEZYflag (Addgene plasmid \# 18700) Gateway destination vectors, which were gifts from Yu-Zhu Zhang ([@bib21]). hCas9_D10A (Addgene plasmid \# 41816), a construct used to generate NDEL1 S332/336A KI, was a gift from George Church ([@bib34]). Core sequences of two guide RNAs targeting mouse *Ndel1* exon nine were TCTTCTCGCCGTAGTGCCGT and ATTGATATCGCGCAGAGTCC.

Cell culture and transfection {#s4-3}
-----------------------------

HEK293 and NIH3T3 cells were cultured in DMEM (HyClone, South Logan, UT, USA) supplemented with 10% (v/v) fetal bovine serum (FBS) (Gibco, Gaithersburg, MD, USA) and 1% penicillin/streptomycin (Gibco). SH-SY5Y cells were grown in MEM supplemented with 10% (v/v) FBS and 1% penicillin/streptomycin and were differentiated by treatment of 10 μM all-trans retinoic acid in MEM supplemented with 2% FBS for more than 3 days. All cell lines were authenticated using STR profiling method and were tested negative for mycoplasma contamination. All cells were transfected by using transfection reagent either VivaMagic (Vivagen, Seongnam, South Korea) or Lipofectamine 2000 (Thermo Fisher Scientific).

Primary cultures of hippocampal neurons were established by isolating E18 SD rat embryo or E15 ICR mouse embryo hippocampal tissues in HBSS (Gibco) and dissociating tissues in 0.25% trypsin (Sigma-Aldrich) and 0.1% DNase I (Sigma-Aldrich) for 10 min at 37°C. Cells were resuspended in Neurobasal medium (Gibco) supplemented with 10 mM HEPES pH 7.4% and 10% (v/v) horse serum for final cell concentration being 4.0 × 10^5^ cells/mL and plated on glass coverslips pre-coated with poly-D-lysine and laminin. After 2 hr of plating, cell medium was replaced to Neurobasal medium containing 2 mM glutamine, 2% (v/v) B27 supplement (Gibco), and 1% (v/v) penicillin/streptomycin. The neurons were transfected 9 hr or 48 hr after plating with Lipofectamine 2000 and medium was replaced to the culture medium 2 hr after transfection.

F-actin fractionation analysis {#s4-4}
------------------------------

Transfected HEK293 cells were lysed in actin fractionation buffer (10 mM Tris pH 7.4, 2 mM MgCl~2~, 1% Triton X-100, 0.2 mM DTT, and 15% glycerol). After homogenization, lysates were subjected to centrifugation at 3,000 rpm for 1 min to remove cell debris. Supernatant fraction (G-actin) and pellet fraction (F-actin) were separated by centrifugation at 100,000 g (4°C) for 1 hr. Fractions were analyzed by immunoblotting.

Human kinome library screening {#s4-5}
------------------------------

The Center for Cancer Systems Biology (Dana Farber Cancer Institute)-Broad Human Kinase ORF collection plasmid kit ([@bib26]; [@bib69])\[2, 5\] was a gift from William Hahn and David Root (Addgene kit \# 1000000014). Each kinase ORF in pDONR-223 vector was cloned into pEZYmyc-His or pEZYflag Gateway destination vectors via LR Clonase II Plus enzyme (Thermo Fisher Scientific) reaction for 4 hr at room temperature followed by transformation into DH5α competent cells and selection from ampicillin-containing LB agar plate. Each kinase ORF expressing clone was confirmed by sequencing analysis.

For screening responsible kinases for NDEL1 S336/S332 phosphorylation, FLAG-NDEL1 plasmid and the expressing clone plasmid were transfected into HEK293 cells and incubated for 48 hr. pEGFP-C3 plasmid and MYC-hTARA construct were transfected with FLAG-NDEL1 to be used as a negative control and a positive control, respectively. Cells were lysed into 1X ELB lysis buffer (50 mM Tris pH 8.0, 250 mM NaCl, 5 mM EDTA, 0.1% NP-40) supplemented with 2 mM NaPPi, 10 mM NaF, 2 mM Na~3~VO~4~, 1 mM DTT, and protease inhibitor cocktail (Roche, Mannheim, Germany). The lysates were subjected to immunoblotting with FLAG antibody. The candidate kinases were selected by the increment of NDEL1 phosphorylation evidenced by the band shift.

Immunoblot assay and immunoprecipitation {#s4-6}
----------------------------------------

Transfected HEK293 cells were lysed in 1X ELB lysis buffer supplemented with 2 mM NaPPi, 10 mM NaF, 2 mM Na~3~VO~4~, 1 mM DTT, and protease inhibitor cocktail (Roche). Mouse brain tissues were isolated from anesthetized and perfused mice followed by homogenization and lysis in 1X modified RIPA lysis buffer (50 mM Tris pH 7.5, 150 mM NaCl, 1% NP-40, 5 mM EDTA, 1% Triton X-100, 0.5% sodium deoxycholate) supplemented with 2 mM NaPPi, 10 mM NaF, 2 mM Na~3~VO~4~, 1 mM DTT, protease inhibitor cocktail (Roche) and 10 U/mL Benzonase nuclease (Sigma-Aldrich). For immunoblotting analysis, proteins were denatured by mixing lysates with 5X SDS sample buffer (2% SDS, 60 mM Tris pH 6.8, 24% glycerol, and 0.1% bromophenol blue with 5% β-mercaptoethanol) and incubating at 95°C for 10 min. Proteins were separated by SDS-PAGE with 9% polyacrylamide gel and transferred to PVDF membrane (Millipore, Billerica, MA, USA). Membranes were blocked with 5% skim milk or 4% bovine serum albumin (BSA) in Tris-buffered saline (20 mM Tris pH 8.0, and 137.5 mM NaCl) with 0.25% Tween20 (TBST) for 30 min and incubated with primary antibodies at 4°C for more than 6 hr and HRP-conjugated secondary antibodies at room temperature for more than 2 hr. Protein signals were detected by ECL solutions (BioRad, Hercules, CA, USA). For IP, lysates were incubated with 1--5 μg of antibody at 4°C for more than 6 hr with constant rotation. Protein-A agarose beads (Roche) washed three times with lysis buffer were mixed with IPed lysates and incubated at 4°C for 2 hr or overnight with constant rotation. Beads were collected by centrifugation, washed three times, and mixed with SDS sample buffer for immunoblotting analysis.

Immunocytochemistry and immunohistochemistry {#s4-7}
--------------------------------------------

For immunocytochemistry, cells were fixed with 4% paraformaldehyde in PBS or 4% paraformaldehyde and 4% sucrose in PBS for 20 min and washed with PBS for three times. Cells were permeabilized with 0.5% Triton X-100 in PBS for 5 min and blocked with 5% goat serum in PBS or 4% BSA in PBS for more than 30 min. For staining proteins, cells were incubated with primary antibodies diluted in the blocking solution for 1 hr at room temperature or overnight at 4°C, washed with PBS for three times, and treated with secondary antibodies diluted in the blocking solution for 1 hr at room temperature.

For sequential immunostaining, cells were incubated with the first primary antibody diluted in the blocking solution for 2 hr followed by two rounds of incubation with Alexa Fluor 488-conjugated secondary antibody in the blocking solution for 1 hr each at room temperature. Cells were washed with PBS for more than three times, incubated with the second primary antibody diluted in the blocking solution for 2 hr at room temperature, and treated with Alexa Fluor 647-conjugated secondary antibody in the blocking solution for 1 hr at room temperature.

For immunohistochemistry, mouse brain slices on slide glass were washed with PBS and additionally fixed with 4% paraformaldehyde in PBS for 20 min. After three times of PBS washing, 0.5% Triton X-100 in PBS was treated for permeabilization for 10 min and 5% goat serum or 5% BSA blocking solution was treated for 1 hr. Primary antibody diluted in blocking solution was treated for overnight at 4°C. After three times of PBS washing, fluorescent-conjugated secondary antibody diluted in blocking solution was treated for 2 hr at room temperature. For sequential staining, it was done as same as immunocytochemistry. Tissue slides were washed with PBS and mounted by using UltraCruz Aqueous Mounting Medium with DAPI (Cat\# sc-24941, RRID:[AB_10189288](https://scicrunch.org/resolver/AB_10189288), Santa Cruz Biotechnology).

Cell images were acquired by using FV3000 confocal laser scanning microscope (Olympus, Tokyo, Japan) and processed by using ImageJ (Fiji) software (RRID:[SCR_002285](https://scicrunch.org/resolver/SCR_002285), National Institute of Health, Bethesda, MD, USA) ([@bib52]). For quantitation of colocalization between NDEL1, TARA, pNDEL1, and IgG control staining patterns, all images were deconvolved using advanced constrained iterative (CI) algorithm-based deconvolution program of cellSens software (Olympus) and were subjected for Pearson's colocalization coefficient analysis through cellSens.

*In utero* electroporation {#s4-8}
--------------------------

Pregnant ICR mice at E15 were anesthetized with an intraperitoneal injection of ketamine (75 mg/Kg) (Yuhan Corporation, Seoul, South Korea) and xylazine (11.65 mg/Kg) (Bayer AG, Leverkusen, Germany) in PBS. Coding sequences of target genes in pCIG2 vectors or shRNA sequences in pLL3.7-EGFP and pLL3.7-mRFP vectors were purified by using EndoFree plasmid maxi kit (Qiagen, Germantown, MD, USA). Each DNA solution (2.0 μg/μL) mixed with Fast Green solution (0.001%) was injected into bilateral ventricles of the embryo through pulled microcapillary tube (Drummond Scientific, Broomall, PA, USA). Tweezer-type electrode containing two disc-type electrodes was located with appropriate angle and electric pulses were given as 35 V, 50 ms, five times with 950 ms intervals by using an electroporator (Harvard Apparatus, Holliston, MA, USA). After electroporation, embryos were put back into the mother's abdomen, the incision was sutured, and mice were turned back to their home cage. The mice were sacrificed at E18 or P14 and brains were fixed with 4% paraformaldehyde in PBS for 24 hr, dehydrated with 10% and 30% sucrose in PBS for more than 24 hr, and soaked and frozen in Surgipath FSC22 Clear OCT solution (Leica Biosystems, Richmond, IL, USA). Brain tissue was sectioned by using cryostats (Leica Biosystems) with 100 μm thickness and each section was immediately bound to Superfrost Plus microscope slides (Fisher Scientific). Brain slice images were acquired by using 10x, 20x, and 40x objective lenses of FV3000 confocal laser scanning microscope (Olympus) with Z-stacks of 1 μm intervals.

*In vitro* axon/dendrite outgrowth assay {#s4-9}
----------------------------------------

Primary cultured rat hippocampal neurons were subjected to transfection at either 9 or 48 hr after plating. The neurons were fixed by 4% (w/v) paraformaldehyde in PBS for 20 min after 72 or 48 hr after transfection for the knockdown group or the over-expression groups, respectively. Cell images were acquired by using a 40x objective lens of fluorescent microscopy and analyzed by using ImageJ software.

*In vitro* phosphatase assay {#s4-10}
----------------------------

Transfected HEK293 cells were lysed in 1X ELB lysis buffer and were IPed with FLAG antibody and protein-A agarose beads to enrich FLAG-tagged NDEL1 proteins. After washing and removal of PBS, beads were incubated with 1X *in vitro* kinase assay buffer (30 mM HEPES pH 7.2, 10 mM MgCl~2~, and 0.2 mM DTT) and 10 units of calf intestinal alkaline phosphatase (CIP, New England Biolabs, Beverley, MA, USA) at 37°C for 30 min. 5X SDS sample buffer was mixed to stop dephosphorylation activity of CIP and to subject for western blot analysis.

Liquid Chromatography (LC)-Mass Spectrometry (MS)/MS Analysis {#s4-11}
-------------------------------------------------------------

To enrich endogenous NDEL1 proteins from P7 mouse brains, brain lysates with total of 20 mg proteins were IPed with 2 μg of anti-NDEL1 antibody. IPed proteins were reduced with 5 mM dithiothreitol for 0.5 hr at 56°C and alkylated with 20 mM iodoacetamide at room temperature in the dark for 20 min followed by in-bead protein digestion with 1 μg trypsin (Promega) at 37°C overnight. The beads were removed by a short spin and digested peptides were desalted with a C18 spin column (\#89870, Thermo Fisher Scientific). The peptides extracted from the IP were analyzed with a nano liquid chromatography (LC) system (Dionex) coupled to a Q-Exactive Plus Orbitrap (Thermo Fisher Scientific). A binary solvent system composed of 0.1% formic acid in water and 0.1% formic acid in acetonitrile was used for all analysis. Peptide fractions were separated on an Ultimate 3000 RSLCnano System with a PepMap 100 C18 LC column (\#164535) serving as a loading column followed by a PepMap RSLC C18 (\#ES803) analytical column with a flow rate of 0.3 μL/min for 135 min. Full scan mass spectrometry (MS) with a data-dependent MS/MS acquisition was performed in a range from 350 to 2000 m/z. All raw LC-MS/MS data were processed with Proteome Discoverer 2.2 (Thermo Fisher Scientific). Data were filtered to a 1% false discovery rate and searched for dynamic phosphorylation modifications (79.966 Da) at a fragment mass tolerance setting of 0.02 Da.

Lysosomal trafficking assay {#s4-12}
---------------------------

Primary cultured mouse hippocampal neurons were subjected to transfection of GFP-LAMP1 with indicated constructs at DIV 5--7 and imaged at 37°C with supplying 5% CO~2~ gas by using FV3000 confocal laser scanning microscope. Through FV31S-DT software (Olympus), a 50 μm-length region of interest (ROI) at the axon was determined and recorded for total 3 min with 1 s interval. Generation of kymographs and data analysis were performed by using CellSens and ImageJ using the KymoAnalyzer v1.01 plug-in ([@bib37]) combined with manual analysis.

Neuronal dendritic morphology analysis {#s4-13}
--------------------------------------

For neuronal dendritic morphology analysis, mouse embryos were electroporated *in utero* at E15 and sacrificed at P14. From sectioned brain slices, the somatosensory cortex was located based on mouse brain atlas with hippocampal structure and cortical layer II-IV was distinguished by DAPI staining pattern. Each layer II/III pyramidal neuron in which cell soma is located in the middle of Z-stacks with clearly observable apical dendritic structure was subjected for analysis. Apical and basal dendritic morphologies of each selected neuron were traced out by using Simple Neurite plug-in of ImageJ or Imaris software (Bitplane, Zurich, Switzerland) and total length, the longest length, number of branches, and number of primary/secondary dendrites were measured. For Sholl analysis, the tracing data were subjected to Sholl Analysis plug-in of ImageJ by 10 μm radius step size.

Time-lapse live imaging with FRAP assay {#s4-14}
---------------------------------------

To test F-actin or microtubule dynamics, differentiated SH-SY5Y cells expressing either RFP-LifeAct or mCherry-α-tubulin were imaged at 37°C with supplying 5% CO~2~ gas by using FV3000 confocal laser scanning microscope. Through FV31S-DT software, either a 10 μm-radius circular region of interest (ROI) around cellular process tips for F-actin dynamics or 6 μm x 3 μm rectangular ROI at the middle of the cellular process for microtubule dynamics was determined. The ROI was photobleached by scanning with 10% power 568 nm laser and 20 μs/pixel scan speed for total 10 s. For FRAP analysis, five frames were acquired as pre-bleach images followed by bleaching and 150 frames were acquired as post-bleach with each 2 s interval. FRAP results were analyzed by automatically with the easyFRAP-web application ([@bib29]) combined with additional manual analysis.

Statistical analysis {#s4-15}
--------------------

All graphs were presented as the mean ± SEM. Statistical significance of the data was analyzed by two-tailed Student's t-test for comparisons between two groups and one-way or two-way ANOVA followed by Bonferroni's post-hoc test for comparisons among multiple groups.
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**Decision letter after peer review:**

Thank you for submitting your article \"Sequential phosphorylation of NDEL1 by the DYRK2-GSK3β complex is critical for neuronal morphogenesis\" for consideration by *eLife*. Your article has been reviewed by Marianne Bronner as the Senior Editor, a Reviewing Editor, and three reviewers. The following individuals involved in review of your submission have agreed to reveal their identity: Yuanyi Feng (Reviewer \#1); Deanna Smith (Reviewer \#2).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

Reviewers recognize the intriguing evidence that TARA acts as a scaffold for NDEL1 and two kinases, DYRK2 and GSK3β, identified using a human kinome screen, and agree that the *in vitro* data supporting the model that DYRK2 phosphorylation NDEL1 S336 primes phosphorylation by GSK3β at S332, and that phosphorylation impacts filamentous actin but not microtubules. However, there are two major concerns raised that reviewers would like to see addressed before the work can move forward at *eLife*. First, all reviewers point out that the work is predominantly limited to tagged proteins, so whether the interactions described also occur with endogenous proteins remains a question. Second, all reviewers request genetic evidence for this interaction other than overexpression, or at the minimum, the protein levels of NDEL1 or pNDEL1 (in the shRNA -- overexpression rescue experiments) need to be better controlled for physiological levels. NDEL1 may bind many molecules, data from KD or expression by the CAG promotor are very difficult to interpret unless they are expressed at the right levels (i.e. either null or native).

Essential revisions:

1\) Authors should look at other known NDEL1 interactions, and to determine whether the interactions described in this paper also occur with endogenous proteins.

2\) Reviewers request genetic evidence, ideally knock in of the non-phosphorylatable or pseudo-phosphorylated residue to demonstrate in vivo evidence of the requirement of these events for neuronal morphogenesis. If not possible, at the minimum, the protein levels of NDEL1 or pNDEL1 (in the shRNA -- overexpression rescue experiments) should be controlled to ensure physiological relevance.

3\) Is Ndel1 expressed and KD in neuronal (as opposed to glial) progenitors? To understand the function of pNDEL1 phosphorylation, it is necessary to understand cell type (progenitor/neuron/glia) and development stage-specificity of the S332/S336 phosphorylation. However, the phospho antibody also recognizes the native NDEL1, making it difficult to tease this out.

4\) The ideal experiment would be to demonstrate reduction of NDEL1 phosphorylation following kinase knockdown (in this paper, only kinase overexpression is performed). However, since this is probably quite challenging, the authors should at least (a) quantify the increase in pNDEL1 signal following kinase overexpression and (b) try to demonstrate the presence of this phosphorylation in another way (phos-Tag gel, MS?). It is not entirely clear to me why the FLAG-NDEL1 shows such a dramatic shift in the kinome experiment (Figure 1---figure supplement 1), but not endogenous NDEL1.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

Thank you for resubmitting your work entitled \"Sequential phosphorylation of NDEL1 by the DYRK2-GSK3β complex is critical for neuronal morphogenesis\" for further consideration by *eLife*. Your revised article has been evaluated by Marianne Bronner (Senior Editor) and Joseph Gleeson (Reviewing Editor).

The manuscript has been improved but there are some remaining issues that need to be addressed before acceptance, as outlined below. The authors provided thorough responses to the critiques and added high quality new data to address many questions raised by reviewers. The new actin-based mechanism shown by this study appears independent of NDEL1\'s brain partners, and the developmental analyses of the revised manuscript remain partially unclear due to the lack of specificity of the experiments. The remaining issues could be addressed experimentally or through better description of the possible interpretation or limitations of the approaches applied.

1\) Authors acknowledged that the NDEL1 promoter is very weak. In this case, it is concerning to use even the UBC promoter, as there was no information to justify the level of expression delivered by electroporation. Moreover, the effect of loss of NDEL1/pNDEL1 function on neuronal morphology was assessed by knockdown electroporation at E15, but it is not clear how effect knockdown or replacement worked, or the cell types affected (i.e. NPC, glial progenitor, etc).

2\) Reviewers remain unconvinced that there is no impact on MTs. The microtubule co-sedimentation assay ([Author response image 6](#respfig6){ref-type="fig"}) suggests that in the presence of overexpressed GFP-TARA, there is more flag-pNDEL1in the soluble fraction than in the absence overexpressed GFP-TARA. This suggests that the interaction between TARA and NDEL1 might impact the interaction of NDEL1 and MTs.

3\) The lysosome trafficking study did not include NDEL1 alone. It is possible that TARA might impact the effect of NDEL1 with respect to organelle trafficking. For example, NDEL1 alone might increase retrograde organelles more than NDEL1S332/336A regardless of TARA, or both WT and mutant NDEL1 could impact transport more in the absence or TARA. This is relevant to the interesting model shown in Figure 7 and may suggest that TARA and the kinases regulate an interplay between F-actin- and MT- associated NDEL1.

4\) Please explain the mass spec data from brain (Figure 1D) and HEK293 cells overexpressing NDEL1 and TARA (Figure 4B). From these figures it seems to indicate that S332 is phosphorylated in brain but not in the HEK293 cells. Is that correct?

5\) The SSSSC splice variant of NDE1 could potentially be targeted by these kinases (Bradshaw et al., 2013). Which isoform was tested here?

10.7554/eLife.50850.sa2

Author response

> Essential revisions:
>
> 1\) Authors should look at other known NDEL1 interactions, and to determine whether the interactions described in this paper also occur with endogenous proteins.

In response to the reviewer's suggestion regarding known NDEL1 interactors, we performed a series of co-immunoprecipitation (co-IP) experiments with LIS1 (*PAFAH1B1*) and DYNC1I1 (cytoplasmic dynein 1 intermediate chain 1). When we compared NDEL1 WT and NDEL1 S332/336A mutant, there was no significant difference in the interaction with LIS1 or DYNC1I1 (Figure 6---figure supplement 2, in the revised manuscript). We were not able to detect co-IP of TARA with either LIS1 or DYNC1I1 ([Author response image 1](#respfig1){ref-type="fig"}). These results support the notion that the NDEL1 S336/S332 phosphorylation is less associated with microtubule dynamics.

![coIP results to examine interactions between TARA and LIS1 or TARA and dynein intermediate chain.](elife-50850-resp-fig1){#respfig1}

To address the point regarding the protein interactions at the endogenous level, we conducted the co-IP experiments from HEK293 cell lysates and P7 mouse brain lysates. Endogenous TARA was detected in co-immunoprecipitates with endogenous GSK3β protein in the lysates of both developing brain and HEK293 cells ([Author response image 2](#respfig2){ref-type="fig"} and Figure 4E). DYRK2 was also co-IPed with TARA in HEK293 cell lysates (Figure 4D), but we could not test the IP in mouse brain lysates due to the species specificity of the antibody application. Overall, we believe that the interactions shown in overexpression conditions are mostly recapitulated at the endogenous protein level. With these additional data, we revised Figure 4.

![The protein-protein interaction between endogenous GSK3β and endogenous TARA in the developing mouse brain.](elife-50850-resp-fig2){#respfig2}

> 2\) Reviewers request genetic evidence, ideally knock in of the non-phosphorylatable or pseudo-phosphorylated residue to demonstrate in vivo evidence of the requirement of these events for neuronal morphogenesis. If not possible, at the minimum, the protein levels of NDEL1 or pNDEL1 (in the shRNA -- overexpression rescue experiments) should be controlled to ensure physiological relevance.

In response to the reviewer's comment, we designed the CRISPR-based knock-in construct targeting mouse *Ndel1* gene corresponding to exon 9 in order to substitute S332 and S336 to alanine residues and to fuse EGFP at the C-terminus of NDEL1 (Figure 2---figure supplement 2A). As a control, we also designed a donor DNA plasmid lacking S336/S332 mutations but still containing EGFP insertion. KI efficacy was validated in the NIH3T3 cell-lines (Figure 2---figure supplement 2B-C).

At first, we attempted to utilize these reagents for *in utero* electroporation at E15 embryonic brains. However, it was extremely challenging to collect the neurons in the electroporated brain that has proper EGFP expression, and thus we failed to obtain a meaningful number of neurons to analyze. We believe that the reasons are multiple layers; (1) All four constructs (dCas9^D10A^, two guide RNAs, and corresponding donor DNA plasmids) have to be successfully transfected. (2) The intrinsic knock-in rate is supposed to be also very low (Uemura et al., 2016; Yao et al., 2018). (3) The NDEL1 promotor appears to be very weak in that rare knock-in cells exhibited very weak fluorescence signals that were not readily distinguishable in the brain section. Combinations of these technical issues prohibited us from going further with this approach.

Alternatively, we applied these reagents to primary neurons. We co-transfected DIV 1 primary mouse hippocampal neurons with dCas9^D10A^, two guide RNAs, and corresponding donor DNA plasmids. When evaluated at DIV 4, axon/dendrite outgrowth was diminished in phospho-deficient (alanine mutant) knock-in neurons relative to wild-type (Figure 2G-I, Figure 2---figure supplement 1E-F). This result further strengthens our claim that NDEL1 S336/S332 phosphorylation impacts neuronal morphogenesis.

We also checked the potential issues related to the expression level of the transgene expressions. For this, the constructs expressing NDEL1 WT or S332/336A under UBC promoter, a low-expression promoter widely used in the fields, were generated. Western blot analysis confirmed that the UBC promoter drives considerably lower NDEL1 expression levels than CAG promoter (Figure 2---figure supplement 1G). The lower-expression of NDEL1^WT^ still effectively rescued NDEL1 knockdown effect in axon/dendrite outgrowth of primary rat hippocampal neurons, while NDEL1^S332/336A^ mutant failed to reverse the phenotype (Figure 2---figure supplement 1H-K). The low-expression NDEL1 constructs were also effective in the reversal of NDEL1 knockdown phenotype on dendritic arborization in P14 cortical layer II/III pyramidal neurons in the *in utero* electroporation (Figure 3---figure supplement 1L-N). Thus, we suppose that the expression level issue in our experimental setting does not seem to affect our interpretation of the results.

> 3\) Is Ndel1 expressed and KD in neuronal (as opposed to glial) progenitors? To understand the function of pNDEL1 phosphorylation, it is necessary to understand cell type (progenitor/neuron/glia) and development stage-specificity of the S332/S336 phosphorylation. However, the phospho antibody also recognizes the native NDEL1, making it difficult to tease this out.

For axon/dendrite outgrowth assay from primary cultured hippocampal neurons, we analyzed the isolated cells with a significantly long single axon with multiple short and branched dendrites to exclude other cell types especially glial cells and undifferentiated cells. For dendritic arborization assay, cells located at the cortical layer II/III of somatosensory cortex were subjected to confocal imaging after determining this region based on Hoechst/DAPI nucleus staining patterns, the structure of hippocampus, and mouse brain atlas reference maps. Also, only cells with pyramidal cell-like soma shapes and proper apical dendritic structure (visible of stretching to the pial surface) were chosen for analyses. For this, we believe that the phenotype we see is likely a consequence of neuron-autonomous effects.

Attempting to address the reviewer's point experimentally, we tried IUE in later stage, E17, where an *in utero* electroporation largely affects progenitors scheduled to be glial cells minimally affecting neuronal cell progenitors in the developing mouse brain (Kohwi and Doe, 2013; LoTurco et al., 2009; Miller and Gauthier, 2007; Taniguchi et al., 2012). When E17 embryos were subjected to IUE with NDEL1 shRNA constructs and analyzed at P14, affected cells were mostly localized around ventricular and subventricular zone (VZ/SVZ) and failed to reach to the cortical layers where most of our analyses focused on ([Author response image 3](#respfig3){ref-type="fig"}). This confirms that the neuronal phenotypes characterized in this study were less likely to be attributable to glial cells.

![Comparison of cell-types affected by *in utero* electroporation at either E15 or E17.](elife-50850-resp-fig3){#respfig3}

To examine the developmental stage-specificity of NDEL1 S336/S332 phosphorylation, we attempted to quantify pNDEL1 in the mouse brain lysates from multiple developmental stages. We enriched endogenous proteins by IP with pan-NDEL1 antibody for detection efficiency and measured the amount of S336/S332 phosphorylation by anti-pNDEL1 immunoblotting. In the result, the ratio of pNDEL1/NDEL1 peaked at in the developmental periods from E18 to P7 at which neuronal maturation and extensive axon/dendrite outgrowth and branching are to be active, supporting the importance of the phosphorylations in those process (Figure 1E in the revised manuscript).

> 4\. The ideal experiment would be to demonstrate reduction of NDEL1 phosphorylation following kinase knockdown (in this paper, only kinase overexpression is performed). However, since this is probably quite challenging, the authors should at least (a) quantify the increase in pNDEL1 signal following kinase overexpression and (b) try to demonstrate the presence of this phosphorylation in another way (phos-Tag gel, MS?). It is not entirely clear to me why the FLAG-NDEL1 shows such a dramatic shift in the kinome experiment (sup Figure 1---figure supplement 1), but not endogenous NDEL1.

As the reviewer suggested, we quantified the increment of endogenous pNDEL1 signal after we replaced the Western blot images with improved quality (previously Figure 1G, now moved to Figure 1F). Since it was technically tricky to clearly distinguish endogenous pNDEL1 signal from the strong signal of antibody heavy chains, we utilized VeriBlot secondary antibodies (Abcam), which minimally bind to denatured IgG, and we were able to improve our pNDEL1 blot quality significantly. Indeed, we were able to detect a significant increment of endogenous NDEL1 S336/S332 phosphorylation in response to kinases over-expression.

Also, we elaborated the description of MS/MS analysis results of endogenous NDEL1 from mouse developing brain and over-expressed NDEL1 from HEK293 cells (Figure 1C-D, Figure 1---figure supplement 3, Figure 4B, and Figure 4---figure supplement 2).

To further solidify the results from Western blot and LC-MS/MS analysis, we examined the phosphorylation status of NDEL1 using phospho-serine residue-specific antibody (PhosphoSerine Antibody Q5, Qiagen). The NDEL1-specific phosphoserine signal was increased upon TARA over-expression (Figure 4---figure supplement 1C), supporting TARA-mediated phosphorylation of NDEL1.

The band shifts of NDEL1 by its phosphorylations have been reported by previous studies (Niethammer et al., 2000; Yan et al., 2003). To answer the reviewer's comment regarding as "It is not entirely clear to me why the FLAG-NDEL1 shows such a dramatic shift in the kinome experiment (Figure 1---figure supplement 1), but not endogenous NDEL1", we prepared an endogenous NDEL1 blot image with additional band shift by DYRK2-GSK3β over-expression ([Author response image 4](#respfig4){ref-type="fig"}). In our experience, from 9\~10% poly-acrylamide gel, FLAG-NDEL1 had considerable band shifts upon phosphorylations. Therefore, in order to detect the NDEL band shifts with high efficiency and sensitivity in the large scale kinome screening, we used FLAG-NDEL1 and FLAG antibody. Accordingly, we elaborated Materials and methods section.

![Existence of endogenous NDEL1 band shift induced by DYRK2-GSK3β over-expression.](elife-50850-resp-fig4){#respfig4}
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\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

> The manuscript has been improved but there are some remaining issues that need to be addressed before acceptance, as outlined below. The authors provided thorough responses to the critiques and added high quality new data to address many questions raised by reviewers. The new actin-based mechanism shown by this study appears independent of NDEL1\'s brain partners, and the developmental analyses of the revised manuscript remain partially unclear due to the lack of specificity of the experiments. The remaining issues could be addressed experimentally or through better description of the possible interpretation or limitations of the approaches applied.
>
> 1\) Authors acknowledged that the NDEL1 promoter is very weak. In this case, it is concerning to use even the UBC promoter, as there was no information to justify the level of expression delivered by electroporation. Moreover, the effect of loss of NDEL1/pNDEL1 function on neuronal morphology was assessed by knockdown electroporation at E15, but it is not clear how effect knockdown or replacement worked, or the cell types affected (i.e. NPC, glial progenitor, etc).

We apologize for this confusion from our response to the essential comment \#2. We wanted to mean by the statement that EGFP-NDEL1 expression under endogenous NDEL1 promoter was not strong enough to be used for the analysis of dendritic morphology of KI neurons in the brain slice culture, which does not necessarily mean that the endogenous expression of NDEL1 is too weak to be functional in the brain development. Indeed, in cultured primary neurons on coverslips, we were able to analyze the neuronal morphology after KI (Figure 2G-I). Also, when we carry out immunohistochemistry with anti-pNDEL1 antibody, we found endogenous pNDEL1 signal was diminished by NDEL1 knockdown in the electroporated neurons (Figure 1---figure supplement 2D). Moreover, quantitative analysis of NDEL1 S336/S332 phosphorylation in mouse brain lysates from various developmental stages indicated the significant level of NDEL1 phosphorylation encompassing E15, E18, and P7 (Figure 1E). We believe that these observations can support the impact of knockdown and replacement constructs on dendritic arborization after that electroporation at E15.

We agree with the reviewer's concern that NDEL1 expression by UBC promoter is still overexpression condition, although it is significantly lower than CAG promoter. We would like to cautiously emphasize that overexpression by CAG promoter and UBC promoter induced indistinguishable strength of phenotype. Moreover, the overexpressed NDEL1^S332/336A^ under CAG or UBC promoters still failed to rescue NDEL1 knockdown effect on the neuronal morphology. Furthermore, when we over-express NDEL1 alone by CAG promoter, there was no significant effect on neuronal morphogenesis despite its high expression level ([Author response image 5](#respfig5){ref-type="fig"}), which further supports the notion that the roles for NDEL1 phosphorylations in the neuronal morphogenesis shown in this work are less likely due to an overexpression artifact. Accordingly, we revised our manuscript to reflect this notion (see subsection "Phosphorylation of NDEL1 S336/S332 regulates neuronal morphogenesis").

![Neuronal morphogenesis with single over-expression of TARA, NDEL1^WT^, or NDEL1^S332/336A^.](elife-50850-resp-fig5){#respfig5}

Existence of endogenous NDEL1 band shift induced by DYRK2-GSK3β over-expression

While we think that the results including cultured primary neurons suggest that our observations are relatively neuron-autonomous effect, we also agree that we cannot fully exclude the contribution of neuron-nonautonomous effects in the *in utero* electroporation approach. Accordingly, we revised our manuscript to reflect this notion (see subsection "Phosphorylation of NDEL1 S336/S332 regulates neuronal morphogenesis").

> 2\) Reviewers remain unconvinced that there is no impact on MTs. The microtubule co-sedimentation assay ([Author response image 6](#respfig6){ref-type="fig"}) suggests that in the presence of overexpressed GFP-TARA, there is more flag-pNDEL1in the soluble fraction than in the absence overexpressed GFP-TARA. This suggests that the interaction between TARA and NDEL1 might impact the interaction of NDEL1 and MTs.

We agree with the reviewer\'s concerns in that the basis of our claim that the NDEL1 S336/S332 phosphorylation effect is rather specific to the actin-related events is the limited aspects of microtubule functionalities, which does not allow us to exclude the possibility of NDEL1 S336/S332 phosphorylation-dependent microtubule functions. In regards to [Author response image 6](#respfig6){ref-type="fig"}, the result could be interpreted in multiple ways and cannot be the basis of excluding the additional roles of the phosphorylation in NDEL1-MT interaction. Accordingly, we revised our manuscript toning down the claim related to this point wherever necessary (Abstract, subsection "Phosphorylation of NDEL1 S336/S332 enhances F-actin dynamics", and the Discussion section).

![](elife-50850-resp-fig6){#respfig6}

> 3\) The lysosome trafficking study did not include NDEL1 alone. It is possible that TARA might impact the effect of NDEL1 with respect to organelle trafficking. For example, NDEL1 alone might increase retrograde organelles more than NDEL1S332/336A regardless of TARA, or both WT and mutant NDEL1 could impact transport more in the absence or TARA. This is relevant to the interesting model shown in Figure 7 and may suggest that TARA and the kinases regulate an interplay between F-actin- and MT- associated NDEL1.

While we were preparing the first revision regarding Figure 6---figure supplement 3, we initially tested the NDEL1 alone and NDEL1^S332/336A^ alone in a preliminary set of experiments and we were not able to see the difference between WT and mutant NDEL1 group in the fraction of motile lysosome. We thought the capacities of WT and mutant NDEL1 to impact on lysosome trafficking were not different in this experimental setting potentially due to stoichiometric imbalance between NDEL1 and TARA, so we switched to TARA co-expression condition to sensitize the potential impact of the phosphorylation as in other assays we used (Figure 5). Indeed, the lysosome phenotype remained indistinguishable in this condition. Again, we agree that we cannot exclude the possibility that TARA-mediated phosphorylation modulates the association of NDEL1 with microtubule. Accordingly, we further elaborated the description of related part in the manuscript. (Discussion section).

> 4\) Please explain the mass spec data from brain (Figure 1D) and HEK293 cells overexpressing NDEL1 and TARA (Figure 4B). From these figures it seems to indicate that S332 is phosphorylated in brain but not in the HEK293 cells. Is that correct?

We apologize for the less clear presentation of the data. To clarify, we were able to recover an ionized fragment that predicts pS336 from the HEK293 sample, and we recovered an ionized fragment corresponding to pS332 or pS336 from the mouse brain sample. Due to technical limitations of LC-MS/MS technique and S/T-rich nature of NDEL1 carboxyl terminus, we had to admit that MS data is not conclusive enough to definitely claim the dual phosphorylation of S332 and S336 on its own. However, in conjunction with other biochemical data including phospho-specific antibody data and mutagenesis data, etc., this data supports our finding that S332 and S336 are targets of phosphorylation.

For better description of the data, we elaborated on the LC-MS/MS data in Figure 1D and Figure 4B and corresponding descriptions (subsection "DYRK2 and GSK3β induce sequential phosphorylation of NDEL1 at S336 and S332", and subsection "TARA recruits DYRK2 and GSK3β to induce sequential phosphorylation of NDEL1 S336/S332").

> 5\) The SSSSC splice variant of NDE1 could potentially be targeted by these kinases (Bradshaw et al., 2013). Which isoform was tested here?

Here, we used a mouse NDE1 with canonical sequence (UniProtKB/Swiss-Prot ID: Q9CZA6-1, CCDS ID: CCDS37263.2). This isoform has similar size (human/mouse NDEL1: 345 a.a., mouse NDE1: 344 a.a.) but different C-terminal sequences with human/mouse NDEL1 protein (Please see Figure 1 of Bradshaw et al., 2013). Accordingly, we added this information in subsection "Antibodies and plasmids".

[^1]: SK Biopharmaceuticals Ltd, Republic of Korea.

[^2]: LG Chem Ltd, Republic of Korea.
